Shrinkage of uterine fibroids by preoperative LHRH analogue injection

The Ulster medical journal · 1992 · vol. 61(1) , pp. 51–5 · PMID:1535743 · PMC2448785
Other OA: closed
📄 Open PDF View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-08-15 ⓘ

Preoperative goserelin implants reduced uterine fibroid volume by 30-47% and alleviated symptoms in six patients, indicating potential utility for shrinking fibroids prior to hysterectomy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Six patients with large uterine fibroids were given a single subcutaneous implant of an LHRH analogue (goserelin 3.5 mg) prior to elective hysterectomy. Overall fibroid volume decreased by 30-47% within six weeks of implantation. All patients reported improvement in their symptoms of pressure and pain, and were rendered amenorrhoeic prior to surgery.

My notes (saved in your browser only)

MeSH descriptors

Buserelin Leiomyoma Preoperative Care Uterine Neoplasms Adult Buserelin Buserelin Buserelin Combined Modality Therapy Female Goserelin Humans Leiomyoma Leiomyoma Leiomyoma Middle Aged Preoperative Care Uterine Neoplasms Uterine Neoplasms Uterine Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-15T09:34:25.365398+00:00
pubmed
last seen: 2026-10-08T21:02:42.299833+00:00